Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Glactone Pharma Development AB
AB
Active
Advertising protection
Org 5569121121
Kungsportsavenyen 22, 411 36
Göteborg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2012 · 13 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Glactone Pharma Development AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AH
Andreas Henrik Alexander Brodström
Chief Auditor
Chief Auditor
2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
AS
Anders Sigvard Bjartell
Board of Directors
Board of Directors
2020
DM
Daniel Martin Lifveredson
Board of Directors
Board of Directors
2022
JB
Jan Birger Fredrik Törnell
Chairman
Chairman
2020
Former (1)
KR
Karin Rebecka Hellsten
Board of Directors
Board of Directors
2020 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Glactone Pharma AB
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Glactone Pharma Development AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
